Loading company…
Medtide provides peptide-focused contract research, development and manufacturing services for pharmaceutical and life sciences companies.
Founded in 2020 and based in Hangzhou, China, Medtide provides an integrated CRDMO service for peptide-based drug development. Its work spans discovery, preclinical research, clinical development and commercial production for clients in pharmaceuticals and life sciences. The company serves more than 1,000 customers across over 50 countries. It raised USD 10.00 mn in a Pre-IPO round from investors including Dragon Merit Holdings Limited and Welight Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in